Komori
Revision of earnings forecasts6034MRT Inc.Information and Communications, Services and Others

Notice Concerning the Transfer of Shares in a Consolidated Subsidiary and Revisions to Full-Year Earnings Forecasts

All shares in 「医師たちとつくる」 held by the consolidated subsidiary were transferred, and the company was excluded from the scope of consolidation. Accordingly, the forecast for revenue for the fiscal year ending December 2026 was revised downward by ¥350 million, while operating profit was revised upward by ¥25 million and profit attributable to owners of the parent by ¥20 million.

Worth reading
77Important
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
350
¥ million
Wording
Avoiding a definitive answer
How definitive the wording is.

Revised forecast

Fiscal year ending December 2026 · Full yearPrevious forecast published 13 February 2026
Net Sales4,300→3,950million
-8.1%
Operating profit170→195million
+14.7%
Profit attributable to owners of the parent109→129million
+18.3%
Net income per share19.06→23.31yen
+22.3%

The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.

Reason for the revision

Overall revenue will decline because revenue from discontinued operations will be excluded following the removal of 「医師たちとつくる」 and 「ドクターズブライト」 from the scope of consolidation and the termination of the 「ネット医局」 service, while operating profit is expected to increase through the efficient reallocation of management resources. Revenue from continuing operations is expected to increase by 3.2% year on year.

Previous-period resultsRevenue ¥3,829 million (yen for earnings per share) / Operating profit ¥73 million (yen for earnings per share) / Profit before tax ¥86 million (yen for earnings per share) / Profit for the year attributable to owners of the parent ¥55 million (yen for earnings per share) / Earnings per share ¥9.91 million (yen for earnings per share) / Notes Amounts for continuing operations, excluding discontinued operations. Figures prior to the audit by the audit firm.
Consolidated / non-consolidatedConsolidated
Revised forecast
ItemDetails
Net Sales¥4,300 million → ¥3,950 million(-8.1%)
Operating profit¥170 million → ¥195 million(+14.7%)
Profit attributable to owners of the parent¥109 million → ¥129 million(+18.3%)
Net income per share19.06 yen → 23.31 yen
Fiscal Period CoveredFiscal year ending December 2026
Period CoveredFull year
Publication date of previous forecast13 February 2026
Previous-period resultsRevenue ¥3,829 million (yen for earnings per share) / Operating profit ¥73 million (yen for earnings per share) / Profit before tax ¥86 million (yen for earnings per share) / Profit for the year attributable to owners of the parent ¥55 million (yen for earnings per share) / Earnings per share ¥9.91 million (yen for earnings per share) / Notes Amounts for continuing operations, excluding discontinued operations. Figures prior to the audit by the audit firm.
Reason for the revisionOverall revenue will decline because revenue from discontinued operations will be excluded following the removal of 「医師たちとつくる」 and 「ドクターズブライト」 from the scope of consolidation and the termination of the 「ネット医局」 service, while operating profit is expected to increase through the efficient reallocation of management resources. Revenue from continuing operations is expected to increase by 3.2% year on year.
Consolidated / non-consolidatedConsolidated
Items this document does not state (3)
Ordinary incomeDetails and amount of extraordinary lossDividend forecast revision

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Overall revenue will decline because revenue from discontinued operations will be excluded following the removal of non-core businesses from the scope of consolidation, the sale of shares in 「ドクターズブライト」, and the termination of the 「ネット医局」 service. At the same time, operating profit is expected to increase as management resources are reallocated to core businesses through a review of the business portfolio, improving operating efficiency.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning the Transfer of Shares in a Consolidated Subsidiary and Revisions to Full-Year Earnings Forecasts | MRT Inc. (6034) timely disclosure | Komori